The Latest

Ractigen Therapeutics Announces Completion of Enrollment and First Dosing in Phase II Clinical Trial of RAG-17 for SOD1-ALS

NANTONG, China, Aug. 6, 2026 /PRNewswire/ — Ractigen Therapeutics, a clinical-stage biotechnology company…
  • August 6, 2026

Daqo New Energy to Announce Unaudited Financial Results for the Second Quarter of 2026 on August 20, 2026

SHANGHAI, Aug. 6, 2026 /PRNewswire/ — Daqo New Energy Corp. (NYSE: DQ)…
  • August 6, 2026
Sharon AI Reports Second Quarter 2026 Results

Sharon AI Reports Second Quarter 2026 Results

Total contract value reaches ~$8.8bn  Six-year strategic NVIDIA compute collaboration Secured AI…
  • August 6, 2026
Run AI Where It Matters–At the Edge

Run AI Where It Matters–At the Edge

Deploy real-time inference on-site with Winmate Edge AI Panel PCs and WNAI-E800…
  • August 6, 2026

Immune Mediated Disease Therapeutics Developer Attovia Therapeutics Debuts on Nasdaq

SHANGHAI, Aug. 6, 2026 /PRNewswire/ — Attovia Therapeutics, a portfolio company of…
  • August 6, 2026

NetEase to Report Second Quarter 2026 Financial Results on August 20

HONG KONG, Aug. 6, 2026 /PRNewswire/ — NetEase, Inc. (NASDAQ: NTES and…
  • August 6, 2026

Youdao to Report Second Quarter 2026 Financial Results on August 20

HANGZHOU, China, Aug. 6, 2026 /PRNewswire/ — Youdao, Inc. ("Youdao" or the…
  • August 6, 2026
LONGi Becomes Official Partner of FC Bayern Munich, Uniting Solar Energy Innovation and Football Passion

LONGi Becomes Official Partner of FC Bayern Munich, Uniting Solar Energy Innovation and Football Passion

Announced in Hong Kong during FC Bayern Munich’s Asia visit, the global…
  • August 6, 2026